-
公开(公告)号：EP1761529B1
公开(公告)日：2007-11-14
申请号：EP05751627.0
申请日：2005-06-16
申请人： Novartis AG , NOVARTIS-PHARMA GMBH
发明人： BALA, Kamlesh, Novartis Horsham Research Centre , LEBLANC, Catherine, Novartis Horsham Research Ctr. , SANDHAM, David Andrew, Novartis Horsham Res. Ctr. , TURNER, Katharine L., Novartis Horsham Res. Ctr. , WATSON, Simon James, Novartis Horsham Res. Ctr. , BROWN, Lyndon Nigel , COX, Brian, Novartis Horsham Res. Ctr
IPC分类号： C07D471/04 , A61K31/437
CPC分类号： C07D471/04 , A61K31/437 , A61K45/06
摘要： There are provided according to the invention compounds of formula (I), in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.
摘要翻译： 根据本发明提供游离或盐形式的式（I）化合物，其中R 1，R 2，R 3，R 4，R 5，R 6，Q，W，X，m，n和p如说明书 ，制备它们的方法以及它们作为药物的用途。
-
2.发明公开PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS 有权PYRROLOPYRIDINDERIVATE及其作为CRTH2拮抗剂
公开(公告)号：EP1761529A2
公开(公告)日：2007-03-14
申请号：EP05751627.0
申请日：2005-06-16
申请人： Novartis AG , NOVARTIS-PHARMA GMBH
发明人： BALA, Kamlesh, Novartis Horsham Research Centre , LEBLANC, Catherine, Novartis Horsham Research Ctr. , SANDHAM, David Andrew, Novartis Horsham Res. Ctr. , TURNER, Katharine L., Novartis Horsham Res. Ctr. , WATSON, Simon James, Novartis Horsham Res. Ctr. , BROWN, Lyndon Nigel , COX, Brian, Novartis Horsham Res. Ctr
IPC分类号： C07D471/04 , A61K31/437
CPC分类号： C07D471/04 , A61K31/437 , A61K45/06
摘要： There are provided according to the invention compounds of formula (I), in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.
-
公开(公告)号：EP1963322A1
公开(公告)日：2008-09-03
申请号：EP06841297.2
申请日：2006-12-07
申请人： Novartis AG
IPC分类号： C07D471/04 , A61K31/437 , A61P29/00
CPC分类号： C07D471/04
摘要： There are provided according to the invention compounds of formula (I) in free or salt form, wherein R1, R2, R4, R5, R6, A, D, X, W, m and n are as described in the specification, process for preparing them, and their use as pharmaceuticals.
-
公开(公告)号：EP1910314B1
公开(公告)日：2010-09-15
申请号：EP06762705.9
申请日：2006-07-19
申请人： Novartis AG
IPC分类号： C07D235/30 , C07D401/12 , C07D403/04 , C07D405/12 , A61K31/4184 , A61K31/4439 , A61P11/08
CPC分类号： C07D405/12 , C07D235/30 , C07D401/12 , C07D403/04
摘要： Benzimidazole derivatives, methods of preparing the same and their pharmaceutical uses for the treatment of inflammatory diseases including COPD.
-
公开(公告)号：EP1910314A1
公开(公告)日：2008-04-16
申请号：EP06762705.9
申请日：2006-07-19
申请人： Novartis AG
IPC分类号： C07D235/30 , C07D401/12 , C07D403/04 , C07D405/12 , A61K31/4184 , A61K31/4439 , A61P11/08
CPC分类号： C07D405/12 , C07D235/30 , C07D401/12 , C07D403/04
摘要： Benzimidazole derivatives, methods of preparing the same and their pharmaceutical uses for the treatment of inflammatory diseases including COPD.
-
6.发明授权PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS 有权PYRROLOPYRIDINDERIVATE及其作为CRTH2拮抗剂
公开(公告)号：EP1761529B3
公开(公告)日：2011-06-15
申请号：EP05751627.0
申请日：2005-06-16
申请人： Novartis AG
发明人： BALA, Kamlesh, Novartis Horsham Research Centre , LEBLANC, Catherine, Novartis Horsham Research Ctr. , SANDHAM, David Andrew, Novartis Horsham Res. Ctr. , TURNER, Katharine L., Novartis Horsham Res. Ctr. , WATSON, Simon James, Novartis Horsham Res. Ctr. , BROWN, Lyndon Nigel , COX, Brian, Novartis Horsham Res. Ctr
IPC分类号： C07D471/04 , A61K31/437
CPC分类号： C07D471/04 , A61K31/437 , A61K45/06
摘要： There are provided according to the invention compounds of formula (I), in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.
-
公开(公告)号：EP1963322B1
公开(公告)日：2013-08-21
申请号：EP06841297.2
申请日：2006-12-07
申请人： Novartis AG
IPC分类号： C07D471/04 , A61K31/437 , A61P29/00
CPC分类号： C07D471/04
-
公开(公告)号：EP1960398B1
公开(公告)日：2010-09-29
申请号：EP06819000.8
申请日：2006-12-07
申请人： Novartis AG
IPC分类号： C07D471/04 , A61K31/435 , A61P29/00
CPC分类号： C07D471/04
摘要： There are provided according to the invention compounds of formula (I), in free or salt form, wherein R1, R2, R4, R5, R6, A, D, X, W, m and n are as described in the specification, process for preparing them, and their use as pharmaceuticals.
-
公开(公告)号：EP1960398A1
公开(公告)日：2008-08-27
申请号：EP06819000.8
申请日：2006-12-07
申请人： Novartis AG
IPC分类号： C07D471/04 , A61K31/435 , A61P29/00
CPC分类号： C07D471/04
摘要： There are provided according to the invention compounds of formula (I), in free or salt form, wherein R1, R2, R4, R5, R6, A, D, X, W, m and n are as described in the specification, process for preparing them, and their use as pharmaceuticals.
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.017 秒)
